Showing results (2031-2040 of 2,317) with videos related to

Sort By:
Pageof 232
Frontiers in Pharmacology|November 5, 2025
Therapeutic effects of three-strain probiotic combination on slow transit constipation: mechanistic insights into MAPK signaling pathway and gut microbiota restorationLiya Liu, Peiyao Li, Youqin Chen, et al.
Journal of Gynecologic Oncology|June 14, 2024
First-line bevacizumab plus chemotherapy in Chinese patients with stage III/IV epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer: a phase III randomized controlled trialXiaohua Wu, Jihong Liu, Ruifang An, et al.
Chinese Journal of Integrative Medicine|January 12, 2024
Pien Tze Huang Inhibits Proliferation of Colorectal Cancer Cells through Suppressing PNO1 Expression and Activating p53/p21 Signaling PathwayLiu-Jing Cao, Li-Ya Liu, You-Qin Chen, et al.
Bioorganic Chemistry|March 3, 2026
A natural product-hybridization approach toward anticancer drug discovery: synthesis and antitumor evaluation of CTBC6, designed from sulforaphane and magnololCheng Tao, Mingxing Chen, Bing Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 12, 2012
Cediranib plus FOLFOX/CAPOX versus placebo plus FOLFOX/CAPOX in patients with previously untreated metastatic colorectal cancer: a randomized, double-blind, phase III study (HORIZON II)Paulo M Hoff, Andreas Hochhaus, Bernhard C Pestalozzi, et al.
The Lancet. Respiratory Medicine|April 15, 2019
Alectinib versus crizotinib in untreated Asian patients with anaplastic lymphoma kinase-positive non-small-cell lung cancer (ALESIA): a randomised phase 3 studyCaicun Zhou, Sang-We Kim, Thanyanan Reungwetwattana, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 5, 2018
Improvement in Overall Survival in a Randomized Study That Compared Dacomitinib With Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer and EGFR-Activating MutationsTony S Mok, Ying Cheng, Xiangdong Zhou, et al.
Free Radical Biology & Medicine|February 22, 2023
Melatonin ameliorates neurological deficits through MT2/IL-33/ferritin H signaling-mediated inhibition of neuroinflammation and ferroptosis after traumatic brain injuryYuan Gao, Tao Wang, Ying Cheng, et al.
Cell Biology International|September 6, 2021
HGF/c-MET pathway contributes to cisplatin-mediated PD-L1 expression in hepatocellular carcinomaZhan-Sheng Zhang, Ruo-Han Yang, Xin Yao, et al.
Annals of Translational Medicine|March 12, 2021
Docetaxel maintenance therapy versus best supportive care after first-line chemotherapy with different dose docetaxel plus cisplatin for advanced non-small cell lung cancer (TFINE study, CTONG-0904): an open-label, randomized, phase III trialLi Zhang, Shun Lu, Ying Cheng, et al.
Pageof 232